Sign up
Pharma Capital

Pharmaxis Ltd's Gary Phillips reveals completed Phase 3 clinical trial of Bronchitol

Gary Phillips, chief executive officer for Pharmaxis Ltd, speaks with Proactive Investors.


View full PXS profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.